Human Vaccines & Immunotherapeutics

Papers
(The H4-Index of Human Vaccines & Immunotherapeutics is 45. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases696
The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay548
COVID-19 vaccination intention in the UK: results from the COVID-19 vaccination acceptability study (CoVAccS), a nationally representative cross-sectional survey426
A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists242
COVID-19 vaccine hesitancy: misinformation and perceptions of vaccine safety229
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review161
Vaccines and routine immunization strategies during the COVID-19 pandemic153
Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?153
Assessing COVID-19 vaccine literacy: a preliminary online survey152
An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination138
A global pandemic in the time of viral memes: COVID-19 vaccine misinformation and disinformation on TikTok125
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against coronavirus infectious disease (COVID)-19112
Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model106
Willingness-to-pay for a COVID-19 vaccine and its associated determinants in Indonesia104
Extended theory of planned behavior in explaining the intention to COVID-19 vaccination uptake among mainland Chinese university students: an online survey study102
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson97
The COVID-19 vaccine social media infodemic : healthcare providers’ missed dose in addressing misinformation and vaccine hesitancy95
Prospects for mucosal vaccine: shutting the door on SARS-CoV-284
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults84
COVID-19 vaccine hesitancy – reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic80
Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population66
Modification of a vaccine hesitancy scale for use in adult vaccinations in the United States and China65
A systematic literature review of herpes zoster incidence worldwide65
Vaccine hesitancy and its determinants among Arab parents: a cross-sectional survey in the United Arab Emirates62
Vaccine confidence: the keys to restoring trust61
Recombinant vaccines for COVID-1960
Role of antibody-dependent enhancement (ADE) in the virulence of SARS-CoV-2 and its mitigation strategies for the development of vaccines and immunotherapies to counter COVID-1960
Online mis/disinformation and vaccine hesitancy in the era of COVID-19: Why we need an eHealth literacy revolution59
Reactive arthritis after COVID-19 vaccination56
COVID-19 vaccine hesitancy: a survey in a population highly compliant to common vaccinations54
Cytokines and COVID-19: friends or foes?53
Research trends in COVID-19 vaccine: a bibliometric analysis53
COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa52
SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice51
Who should be prioritised for COVID-19 vaccination?50
Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study49
A qualitative study exploring the relationship between mothers’ vaccine hesitancy and health beliefs with COVID-19 vaccination intention and prevention during the early pandemic months49
Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders – Advances and challenges48
PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential48
SARS-CoV-2 reinfection and implications for vaccine development48
Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia47
Reported COVID-19 vaccines side effects among Jordanian population: a cross sectional study47
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges47
How health care providers should address vaccine hesitancy in the clinical setting: Evidence for presumptive language in making a strong recommendation46
Vaccines and vaccination: history and emerging issues45
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions45
Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China45
0.062318086624146